bumetanide has been researched along with Intellectual Disability in 1 studies
Intellectual Disability: Subnormal intellectual functioning which originates during the developmental period. This has multiple potential etiologies, including genetic defects and perinatal insults. Intelligence quotient (IQ) scores are commonly used to determine whether an individual has an intellectual disability. IQ scores between 70 and 79 are in the borderline range. Scores below 67 are in the disabled range. (from Joynt, Clinical Neurology, 1992, Ch55, p28)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Merner, ND | 1 |
| Mercado, A | 1 |
| Khanna, AR | 1 |
| Hodgkinson, A | 1 |
| Bruat, V | 1 |
| Awadalla, P | 1 |
| Gamba, G | 1 |
| Rouleau, GA | 1 |
| Kahle, KT | 1 |
1 other study available for bumetanide and Intellectual Disability
| Article | Year |
|---|---|
Gain-of-function missense variant in SLC12A2, encoding the bumetanide-sensitive NKCC1 cotransporter, identified in human schizophrenia.
Topics: Animals; Autism Spectrum Disorder; Bumetanide; Cohort Studies; Intellectual Disability; Membrane Pot | 2016 |